211 results
8-K
EX-99.1
RIGL
Rigel Pharmaceuticals
5 Mar 24
Rigel Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
4:10pm
risk of severe bleeding events that can result in serious medical complications or even death. Current therapies for ITP include steroids, blood platelet … with lung cancer in 2024. Lung cancer is the leading cause of cancer death in the U.S, with NSCLC being the most common type accounting for 80-85% of all
8-K
EX-99.1
RIGL
Rigel Pharmaceuticals
8 Jan 24
Rigel Pharmaceuticals Provides Business Update
8:30am
risk of severe bleeding events that can result in serious medical complications or even death. Current therapies for ITP include steroids, blood
8-K
EX-99.1
f8puinpomp4dyl2o
7 Nov 23
Rigel Reports Third Quarter 2023 Financial Results and Provides Business Update
4:16pm
8-K
EX-99.1
sanga70 ah
1 Aug 23
Rigel Reports Second Quarter 2023 Financial Results and Provides Business Update
4:15pm
8-K
EX-99.1
v3n56 1lks6awvbp7
2 May 23
Rigel Reports First Quarter 2023 Financial Results and Provides Business Update
4:15pm
8-K
EX-3.1
n649b 55ib782
3 Nov 22
Rigel Reports Third Quarter 2022 Financial Results and Provides Business Update
4:05pm
8-K
EX-99.1
pml7xpmootyvir y0g
3 Nov 22
Rigel Reports Third Quarter 2022 Financial Results and Provides Business Update
4:05pm